Key statistics
On Thursday, Entrada Therapeutics Inc (TRDA:NMQ) closed at 18.05, -11.91% below its 52-week high of 20.49, set on Nov 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.85 |
---|---|
High | 18.40 |
Low | 17.60 |
Bid | 16.03 |
Offer | 27.70 |
Previous close | 17.93 |
Average volume | 145.21k |
---|---|
Shares outstanding | 37.42m |
Free float | 31.86m |
P/E (TTM) | 11.32 |
Market cap | 675.43m USD |
EPS (TTM) | 1.59 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Entrada Therapeutics Reports Third Quarter 2024 Financial Results
- Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society
- Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development
- Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program
- Entrada Therapeutics Reports Second Quarter 2024 Financial Results
- Entrada Therapeutics Announces $100 Million Registered Direct Offering
- Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy
- Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
- Entrada Therapeutics to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
- Entrada Therapeutics Reports First Quarter 2024 Financial Results
More ▼